Skip to main content
. 2022 Apr 14;54(5):102302. doi: 10.1016/j.aprim.2022.102302

Table 5.

Multivariate logistic regression models of poor control of Type 2 Diabetes Mellitus.

Men (n = 257) OR 95%CI P value
Age group (66–79)
 80–84 1.55 0.77–3.13 0.223
 85 and more 1.42 0.69–2.92 0.341



Deprivation Index Quartile (Group 4)
 Group 1 0.84 0.30–2.37 0.736
 Group 2 0.81 0.30–2.21 0.682
 Group 3 0.55 0.18–1.65 0.289



Body mass index (low weight/normal weight)
 Overweight 2.09 0.96–4.53 0.063
 Obesity 3.81 1.61–9.02 0.002



Time of diabetes (≤10 years)
 11–15 years 2.69 1.40–5.17 0.003
 >15 years 3.43 1.60–7.37 0.002



Non-adherence to pharmacological treatment 3.53 1.04–12.02 0.043
Women (n = 468) OR 95%CI P value
Age group (66–79)
 80–84 0.92 0.56–1.51 0.801
 85 and more 1.1 0.68–1.68 0.686
Deprivation Index Quartile (Group 4)
 Group 1 1.38 0.76–2.52 0.495
 Group 2 1.28 0.73–2.23 0.602
 Group 3 1.09 0.61–1.95 0.627
Time with diabetes (≤10 years)
 11–15 years 2.67 1.77–4.05 0.000
 >15 years 2.64 1.67–4.18 0.000
Global (n = 658) OR 95%CI P value
Age group (66–79)
 80–84 0.98 0.63–1.51 0.91
 85 and more 1.15 0.75–1.75 0.527
Deprivation Index Quartile (Group 4)
 Group 1 0.97 0.53–1.77 0.924
 Group 2 0.92 0.52–1.63 0.781
 Group 3 0.58 0.32–1.07 0.082
Body mass index (low weight/normal weight)
 Overweight 1.74 1.10–2.75 0.018
 Obesity 2.12 1.32–3.41 0.002
Time with diabetes (≤10 years)
 11–15 years 2.71 1.83–4.02 0.000
 >15 years 2.88 1.83–4.54 0.000
Sex and Non-adherence to pharmacological treatment (men with adherence)
 Men with non-adherence 3.75 1.12–12.60 0.033
 Women with adherence 1.19 0.83–1.70 0.333
 Women with non-adherence 0.88 0.31–2.50 0.804

The reference category of each variable is shown in parentheses; 95% CI: 95% confidence interval.